Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

380 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Does KRAS testing in metastatic colorectal cancer impact overall survival? A comparative effectiveness study in a population-based sample.
Feigelson HS, Zeng C, Pawloski PA, Onitilo AA, Richards CS, Johnson MA, Kauffman TL, Webster J, Nyirenda C, Alexander GL, Hwang C, Cross D, McCarty CA, Davis RL, Schwarzkopf D, Williams AE, Honda S, Daida Y, Kushi LH, Delate T, Goddard KA; CERGEN Study Team. Feigelson HS, et al. Among authors: kushi lh. PLoS One. 2014 May 1;9(5):e94977. doi: 10.1371/journal.pone.0094977. eCollection 2014. PLoS One. 2014. PMID: 24788807 Free PMC article.
KRAS testing and epidermal growth factor receptor inhibitor treatment for colorectal cancer in community settings.
Webster J, Kauffman TL, Feigelson HS, Pawloski PA, Onitilo AA, Potosky AL, Cross D, Meier PR, Mirabedi AS, Delate T, Daida Y, Williams AE, Alexander GL, McCarty CA, Honda S, Kushi LH, Goddard KA; CERGEN study team. Webster J, et al. Among authors: kushi lh. Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):91-101. doi: 10.1158/1055-9965.EPI-12-0545. Epub 2012 Nov 15. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 23155138 Free PMC article.
The Cancer Research Network: a platform for epidemiologic and health services research on cancer prevention, care, and outcomes in large, stable populations.
Chubak J, Ziebell R, Greenlee RT, Honda S, Hornbrook MC, Epstein M, Nekhlyudov L, Pawloski PA, Ritzwoller DP, Ghai NR, Feigelson HS, Clancy HA, Doria-Rose VP, Kushi LH. Chubak J, et al. Among authors: kushi lh. Cancer Causes Control. 2016 Nov;27(11):1315-1323. doi: 10.1007/s10552-016-0808-4. Epub 2016 Sep 17. Cancer Causes Control. 2016. PMID: 27639398 Free PMC article.
Comparison of recruitment and retention among demographic subgroups in a large diverse population study of diet.
Alexander GL, Dixit-Joshi S, Kushi LH, Coleman LA, Sundaram ME, Clancy HA, Groesbeck M, Potischman NA, Kirkpatrick SI, Zimmerman TP, George SM, Subar AF, Thompson FE. Alexander GL, et al. Among authors: kushi lh. Contemp Clin Trials Commun. 2017 Jun;6:140-146. doi: 10.1016/j.conctc.2017.04.002. Epub 2017 Apr 10. Contemp Clin Trials Commun. 2017. PMID: 28752133 Free PMC article.
Predictors of Long-Term Survival among High-Grade Serous Ovarian Cancer Patients.
Clarke CL, Kushi LH, Chubak J, Pawloski PA, Bulkley JE, Epstein MM, Burnett-Hartman AN, Powell B, Pearce CL, Spencer Feigelson H. Clarke CL, et al. Among authors: kushi lh. Cancer Epidemiol Biomarkers Prev. 2019 May;28(5):996-999. doi: 10.1158/1055-9965.EPI-18-1324. Epub 2019 Apr 9. Cancer Epidemiol Biomarkers Prev. 2019. PMID: 30967418 Free PMC article.
Clinical Molecular Marker Testing Data Capture to Promote Precision Medicine Research Within the Cancer Research Network.
Burnett-Hartman AN, Udaltsova N, Kushi LH, Neslund-Dudas C, Rahm AK, Pawloski PA, Corley DA, Knerr S, Feigelson HS, Hunter JE, Tabano DC, Epstein MM, Honda SA, Ter-Minassian M, Lynch JA, Lu CY. Burnett-Hartman AN, et al. Among authors: kushi lh. JCO Clin Cancer Inform. 2019 Sep;3:1-10. doi: 10.1200/CCI.19.00026. JCO Clin Cancer Inform. 2019. PMID: 31487201 Free PMC article.
380 results